ADA Clinical Practice Guidelines are based on a complete review of the relevant
literature by a diverse group of highly trained clinicians. After weighing the quality
of evidence, from rigorous double-blind clinical trials to expert opinion, recommendations
are drafted, reviewed, and submitted for approval to the ADA Executive Committee;
they are then revised on a regular basis, and subsequently published in Diabetes
View or print the 2015 Clinical Practice Recommendations
We value your feedback on our Clinical Practice Recommendations. If you have thoughts
or suggestions please let us know by clicking here.